References
- Geisler, S., and J. Coller. 2013. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol. 14: 699–712
- Aune, T. M., and C. F. SpurlockIII. 2016. Long non-coding RNAs in innate and adaptive immunity. Virus Res. 212: 146–160
- Sigdel, K. R., A. Cheng, Y. Wang et al. 2015. The emerging functions of long noncoding RNA in immune cells: autoimmune diseases. J. Immunol. Res. 2015: 848790
- Vigneau, S., P. S. Rohrlich, M. Brahic, and J. F. Bureau. 2003. TMEVPG1, a candidate gene for the control of Theiler's virus persistence, could be implicated in the regulation of gamma interferon. J. Virol. 77: 5632–5638
- Collier, S. P., M. A. Henderson, J. T. Tossberg, and T. M. Aune. 2014. Regulation of the Th1 genomic locus from Ifng through TMEVPG1 by T-bet. J. Immunol. 193: 3959–3965
- Wang, Y., P. Wu, R. Lin, et al. 2015. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci. Rep. 5: 13749
- Gomez, J. A., O. L. Wapinski, Y. W. Yang, et al. 2013. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell. 152: 743–754
- Wang, T., Z. Wang, and R. Yang. 2011. Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura. Crit. Rev. Oncol. Hematol. 77: 172–183
- Semple, J. W., Y. Milev, D. Cosgrave, et al. 1996. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood. 87: 4245–4254
- Ogawara, H., H. Handa, K. Morita, et al. 2003. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur. J. Haematol. 71: 283–288
- Wang, T., H. Zhao, H. Ren, et al. 2005. Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica. 90: 914–923
- Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96: 41–101
- Olsson, B., P. O. Andersson, M. Jernas, et al. 2003. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat. Med. 9: 1123–1124
- Zhang, J., D. Ma, X. Zhu, et al. 2009. Elevated profile of Th17, Th1 and Tc1 cells in patients with immune thrombocytopenic purpura. Haematologica. 94: 1326–1329
- Wilson, C. B., E. Rowell, and M. Sekimata. 2009. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9: 91–105
- Li, H., H. Zhao, F. Xue, et al. 2013. Reduced expression of MIR409-3p in primary immune thrombocytopenia. Br. J. Haematol. 161: 128–135
- Zhao, H., W. Du, D. Wang, et al. 2010. The expression of IFN-gamma, IL-4, Foxp3 and perforin genes are not correlated with DNA methylation status in patients with immune thrombocytopenic purpura. Platelets. 21: 137–143
- Rodeghiero, F., R. Stasi, T. Gernsheimer, et al. 2009. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113: 2386–2393
- Collier, S. P., P. L. Collins, C. L. Williams, et al. 2012. Cutting edge: influence of TMEVPG1, a long intergenic noncoding RNA, on the expression of Ifng by Th1 cells. J. Immunol. 189: 2084–2088
- Guo, C., X. Chu, Y. Shi, et al 2012. Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura. J. Clin. Immunol. 27: 557–562
- Qiao, J., Y. Liu, Y. Wu, et al. 2015. Aberrant expression of RUNX3 in patients with immune thrombocytopenia. Int. Immunopharmacol. 28: 252–256
- Shan, N. N., Y. Hu, M. Hou, et al. 2014. Decreased Tim-3 and its correlation with Th1 cells in patients with immune thrombocytopenia. Thromb. Res. 133: 52–56